Albert Labs International CorpCanadian Securities Exchange:ABRTView on Over The Counter Market
- LAST PRICE0.0050
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0050/ 2
- Ask / Lots0.0050/ 2
- Open / Previous Close--- / 0.0050
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Albert Labs International Corp | 372.1K | -0.1x | --- |
Chitogenx Inc | 415.7K | -0.2x | --- |
Many Bright Ideas Technologies Inc | 228.9K | -3.3x | --- |
Enlighta Inc | 256.2K | -1.1x | --- |
WPD Pharmaceuticals Inc | 579.9K | -4.0x | --- |
Mydecine Innovations Group Inc | 617.6K | 0.0x | --- |
Company Information
Albert Labs International Corp. is a Canada-based pharmaceutical drug development company. The Company is focused on active compounds in the treatment of mental health and providing rapid access to effective prescription medicines for people suffering from mental health disorders. The Company operates primarily in one business segment: research and development of drugs to ensure accelerated access to safe and effective psychedelic-assisted therapy for patients with urgent, unmet needs. The Company also focuses on developing solutions through an approved, fast track clinical pathway focusing on Real World Evidence (RWE). The Company's first drug target, KRN-101, is a potential solution for cancer-related anxiety. KRN-101 is derived from natural psilocybin mycelium. Through collaborations with research institutions, hospital centers and government agencies, the Company uses existing clinical infrastructure to deliver and improve patient access to its treatment.
Contact Information
- Headquarters
- 201-6996 Merritt AvenueBURNABY, BC, Canada V5J 4R6
- Phone
- 778-866-1203
- Fax
- 604-893-7033
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $372.1K |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 74.4M |
Albert Labs International Corp does not pay a dividend. | |
Beta | --- |
EPS | $-0.05 |
Book Value | $-0.01 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
